were significantly lower (P<0.001) than wild-type on a 4% salt diet (202±4, 240±5, and 172±3, respectively). Male A 1 KOs and A 2B KOs were not protected against 4% salt diet-induced hypertension. This female advantage was overwhelmed by an 8% salt diet. Female and male A 2A KOs were more salt sensitive, a phenotype that was apparent in male A 2A KOs on 4% and 8% salt diets and in females on 8% salt diet. Female A 1 KOs and A 2B KOs were less susceptible to salt-induced stroke and experienced improved survival. Adenosine receptors influence blood pressure and survival in salt-sensitive rats, and the impact of deleting adenosine receptors on blood pressure and survival depends on salt diet and sex.
A denosine receptors may be involved in blood pressure regulation. A 1 receptors are expressed in the renal microcirculation 1 where they induce renal vasoconstriction, mediate tubuloglomerular feedback, [2] [3] [4] augment renal vasoconstriction induced by angiotensin II 5, 6 and norepinephrine, 7, 8 and are essential for a full renovascular response to renal sympathetic nerve activation. 7, 8 A 1 receptors also mediate vasoconstriction in the aorta 9, 10 and mesenteric arteries, 11, 12 and A 1 receptors in the nucleus tractus solitarii increase sympathetic outflow. 13 In the renal proximal tubules, A 1 receptors stimulate the reabsorption of sodium. [14] [15] [16] [17] [18] A 2A receptors mediate vasodilation in many vascular beds including the kidneys, [19] [20] [21] [22] heart, 23 mesentery, 24, 25 skeletal muscle, 26, 27 and aorta. 28 A 2A receptors inhibit the activity of helper and cytotoxic T lymphocytes, [29] [30] [31] [32] [33] and these effector T cells contribute to the pathophysiology of hypertension. [34] [35] [36] [37] A 2B receptors mediate vasodilation, for example in the kidneys, 38, 39 heart, 23,40,41 mesentery, 11 and aorta. 42 In the renal medullary circulation, A 2 receptors may be critically important in regulating blood pressure by increasing medullary blood flow and thus enhancing sodium excretion. 43, 44 However, A 2B
receptors, by increasing production of endothelin-1 in the kidney may contribute to renal fibrosis and chronic renal failure. 45 Although there is theoretical evidence that adenosine receptors likely participate in blood pressure regulation, the extant literature on this question is sparse, inconsistent, and incomplete (eg, Brown et al 46 ; Kim et al 47 ; Gao et al 48 ; Lee et al 49 ; Sakata et al 50 ; and Nayak et al 51 ). Motivated by the pervasive expression of adenosine A 1 , A 2A , and A 2B receptors in physiological systems related to blood pressure regulation and the paucity of information on whether or not adenosine receptors actually do contribute to blood pressure regulation, we embarked on a comprehensive project to examine the long-term effects of knocking out A 1 , A 2A , and A 2B receptors on hypertension in Dahl salt-sensitive (SS) rats on a normal (0.3%), high (4%), or very high (8%) salt diet. The experiments reported herein were performed by long-term monitoring of blood pressure by radiotelemetry in a large number of animals and included both female and male animals. Here, we report that all 3 adenosine receptors are involved in salt-sensitive hypertension, that the degree of involvement depends not only on the level of salt intake but also on sex, and that knocking out adenosine receptors can affect susceptibility to salt-induced stroke.
Methods
For raw data and for additional information on analytic methods or study materials contact Edwin K. Jackson, PhD at edj@pitt.edu.
Production of Knockout Animals
The University of Pittsburgh Institutional Animal Care and Use Committee approved all procedures, and this investigation conforms to National Institutes of Health Guide for the Care and Use of Laboratory Animals. The knockout rats used in this investigation were generated by the MCW Gene Editing Rat Resource Program (Dr Aron M. Geurts, Department of Physiology and Human Molecular Genetics Center, Medical College of Wisconsin, Milwaukee, WI).
The A 1 receptor knockout rats (A 1 KOs) and A 2A receptor knockout rats (A 2A KOs) were produced by injecting a CRISPR targeting the sequence GGCTCTGCTCGCCATTGCTG for A 1 KOs and GATGTACACCGAGGAGCCCA for A 2A KOs into Dahl SS/ JrHsdMcwi rat embryos. The A 2B receptor knockout rats (A 2B KOs) were also generated in Dahl SS/JrHsdMcwi rat embryos. These rats, however, were produced using ZFN (zinc-finger nuclease) technology and were previously described and characterized by Nayak et al. 51 For all 3 strains, founders were backcrossed into the same parental strain (Dahl SS/JrHsdMcwi). Heterozygous male and female rats of each strain were mated to produce colonies of homozygous knockouts and homozygous wild-type Dahl SS. Figures S1, S2, and S3 in the online-only Data Supplement provide the specific mutations in the Adora1, Adora2a, and Adora2b genes coding for the A 1 , A 2A , and A 2B adenosine receptors, respectively. Also shown are the PCR primers used for genotyping and the predicted sizes of the PCR amplicons. Figure S4 displays typical genotyping results for wild-type and A 1 KO Dahl SS rats using agarose gel electrophoresis of PCR amplicons stained with ethidium bromide and imaged by using a Bio-Rad Gel Doc XR+ System (Product number 1708195; Hercules, CA), and Figure S5 shows the same for wild-type, A 2A KO, and A 2B KO Dahl SS rats. Figures S4 and S5 demonstrate the unambiguous assignment of offspring to their respective genotypes using the indicated primer sets.
Western Blotting for Adenosine Receptors
Methods in the online-only Data Supplement.
Reverse Transcription Quantitative PCR for Assessment of Adenosine Receptor RNA Expression
Acute Hemodynamic Effects of Intravenous Administration of Adenosine Receptor Agonists
Methods in the online-only Data Supplement. 
Effects of Selective

Long-Term Measurement of Arterial Blood Pressure by Radiotelemetry
Breeding pairs and offspring were maintained on a 0.3% salt diet. Offspring were placed into radiotelemetry studies at ≈12 weeks of age. Long-term arterial blood pressures were monitored by radiotelemetry using a Data Sciences International (DSI; St. Paul, MN) system consisting of the following components: Data Exchange Matrix 20CH; Receiver Model RPC-1 for plastic cages; HD-S10 Transmitter with suture rib; Ambient Pressure Reference Model APR-1; DataQuest A.R.T. Silver 4.31 Data Acquisition and Analysis System; and Dell Computer Windows 7 Model 7010. Rats were briefly anesthetized with isoflurane, and the catheter from an HD-S10 transmitter was inserted into the femoral artery and advanced into the abdominal aorta. The transmitter was gently located to the lower body cavity and secured by suture, and the wound was closed by metal clips. Postoperative buprenorphine (0.1 mg/kg) was administered by subcutaneous injection twice daily for 3 days. Rats were housed in plastic cages that were placed on receivers, and arterial pressures were sampled for 15 seconds every 10 minutes. Animals were housed in a temperature (20°C-24°C), humidity (30%-70%), and light/dark cycle (7:00 am-7:00 pm) controlled room within the University of Pittsburgh Division of Laboratory Animal Resources. Three days after implantation of transmitters, baseline blood pressures were recorded for 20 days while the animals continued feeding on the basal 0.3% salt diet. Next, in some rats the rat chow was changed to provide a 4% salt diet, and in other rats (separate groups) the rat chow was changed to provide an 8% salt diet (ie, each rat was placed on either a 4% or 8% salt diet, but not both). Blood pressures were then recorded for an additional 2 weeks. All 3 salt diets were the AIN-76A diet formulated by Research Diets, Inc (New Brunswick, NJ) that contained either 0.3%, 4%, or 8% NaCl. We independently confirmed the sodium content of all the diets by flame photometry. The protein source in the AIN-76A salt diet is casein-based. We selected this diet because Geurts et al 52 have shown that in Dahl SS rats fed the AIN-76A diet baseline arterial blood pressures are much higher and more responsive to a high-salt diet compared with Dahl SS rats fed a grain-based diet.
Statistical Analysis
For basal (ie, 0.3% salt diet) blood pressures and heart rates (HRs), data were analyzed by 2-factor ANOVA in which one factor was genotype and the second factor was sex. To determine the interaction of sex, genotype, and a high (4%) or very high (8%) salt diet on blood pressures and HRs, data were analyzed by a repeated measures 3-factor ANOVA in which one factor was sex, the second factor was genotype, and the third factor was time on the high-salt diet (3 levels: 1 week on the basal 0.3% salt diet, first week on 4% or 8% salt diet, and second week on 4% or 8% salt diet). Additional information was extracted by analyzing females and males separately using a repeated measures 2-factor ANOVA (genotype and time on the salt diet). Specific contrasts were performed by Bonferroni tests. ANOVAs and Bonferroni tests were conducted with NCSS 2004 software (Number Cruncher Statistical Systems; Kaysville, UT). Survival analysis was performed using a Gehan-Breslow-Wilcox test (Prism version 7.00 for Windows, GraphPad Software, La Jolla, CA).
Results
To determine whether the expression of A 1 , A 2A , and A 2B receptors was reduced in our respective knockout rats, we probed for these receptors by Western blot in whole kidney tissue obtained from wild-type and knockout animals. As shown in Figure S6 , in kidney tissue the Western blot signal for the respective target receptor was much lower or absent in respective knockout rats compared with wild-type animals. We also isolated RNA from the kidneys and brains of 3 male and 3 female wild-type, A 1 KO, A 2A KO, and A 2B KO rats (total of 24 rats) and measured RNA expression of native A 1 , A 2A , and A 2B receptors using reverse transcription quantitative PCR. In kidney ( Figure S7 ) and brain ( Figure S8 ) tissue, RNA expression for a given adenosine receptor subtype was, for all intents and purposes, absent in knockout rats for that given receptor subtype, but was readily detectable in wild-type and knockout animals for the other adenosine receptor subtypes. With a few exceptions, adenosine receptor RNA expression was similar in males and females, and the RNA expression of a given receptor subtype was not altered by knockout of the other 2 receptor subtypes. However, in kidney tissue, A 2B receptors were more highly (P<0.05) expressed in female wild-types and A 2A KOs compared with the corresponding males ( Figure S7C ). Also in brain tissue, there was a tendency (not significant) for increased A 2A receptor RNA expression in male and female A 1 KOs and female A 2B KOs compared with wild-type rats ( Figure S8B ).
To determine whether receptor function was altered, we conducted 3 sets of experiments. First, we injected intravenously a bolus (3 μmol/kg) of adenosine while monitoring HR, mean arterial blood pressure (MABP), renal blood flow (RBF), and renal vascular resistance (RVR=MABP/RBF). Figures S9, S10, and S11 illustrate typical responses (HR, MABP, and RVR, respectively) to adenosine in wild-type, A 1 KO, A 2A KO, and A 2B KO Dahl SS rats. In wild-type, A 2A KO and A 2B KO Dahl SS rats, adenosine elicited a profound, yet brief (<1 minute), reduction in HR and MABP and an increase in RVR. These responses are consistent with the well-known ability of cardiac A 1 receptors to mediate adenosine-induced severe bradycardia 53 and renovascular A 1 receptors to mediate adenosine-induced renal vasoconstriction. 18 Consistent with the A 1 KO Dahl SS rats lacking functional A 1 receptors, the effects of adenosine on HR ( Figure S9 ) and RVR ( Figure S11 ) were abolished, yet there was still a reduction in MABP ( Figure S10 ).
To further characterize the A 1 KO, A 2A KO, and A 2B KO Dahl SS rats, we infused intravenously either 2-chloro-N Figure S12 , in A 2A KO and A 2B KO rats, CCPA reduced MABP and HR and increased RVR; and these responses were abolished in A 1 KO rats. In A 1 KO and A 2B KO rats, CGS21680 profoundly decreased MABP, triggered a reflex tachycardia, and reduced MVR ( Figure S13 ). As anticipated, these responses were abolished in A 2A KO rats ( Figure S13 ).
We attempted to confirm that A 2B KO rats did not express functional A 2B receptors by examining the cardiovascular responses to intravenous infusions of BAY60-6583 (selective A 2B receptor agonist). However, we found that activation of A 2B receptors by systemic administration of BAY60-6583 did not stimulate observable acute hemodynamic responses regardless of genotype. Therefore, we took an alternative approach. We previously discovered that A 2B receptors mediate the ability of adenosine to inhibit FBS-induced proliferation of rat cardiac fibroblasts (CFs). 55 Therefore, we isolated and cultured CFs from wild-type, A 1 KO, A 2A KO, and A 2B KO Dahl SS rats and determined the effects of BAY60-6583 on serum-induced proliferation of these cells. As summarized in Figure S14 , BAY60-6583 inhibited serum-induced proliferation of CFs obtained from wild-type, A 1 KO, and A 2A KO Dahl SS rats, but was inactive in this regard in CFs from A 2B KO Dahl SS rats. Thus, this assay system demonstrated that A 2B receptors were nonfunctional in A 2B KO Dahl SS rats.
Confident that the A 1 KO, A 2A KO, and A 2B KO Dahl SS rats had their respective adenosine receptors inactivated, we next proceeded to determine whether baseline blood pressures and HRs were different in wild-type versus adenosine receptor knockout Dahl SS rats on a normal salt diet (0.3% NaCl). To achieve this, a large number (20) (21) (22) (23) (24) (25) (26) (27) (28) (29) of each strain of rats was monitored by radiotelemetry for 20 days. Animals were ≈12 weeks of age at the time of radiotelemetry implant. We had no a priori reason to rule out sex as a biological variable. Therefore, we included a balance of females and males; and we analyzed the data using 2-factor ANOVA in which one factor was sex.
Baseline (ie, on a 0.3% salt diet) MABPs, systolic blood pressures (SBPs), diastolic blood pressures (DBPs), and HRs in female and male A 1 KO and A 2B KO Dahl SS rats are presented in Figures S15 and S16, respectively. Shown are both the day-to-day 24-hour averaged MABPs as well as the overall 20-day averaged MABPs, SBPs, DBPs, and HRs. Compared with wild-type Dahl SS rats, baseline MABPs, SBPs, DBPs, and HRs were not significantly affected by knockout of either A 1 or A 2B receptors; also, there were no significant interactions between sex and genotype in this regard. Unlike A 1 KO and A 2B KO Dahl SS rats, baseline MABPs, SBPs, and DBPs were significantly higher in A 2A KOs versus wild-type rats (P values by 2-factor ANOVA for effect of genotype were P=0.0023, P=0.0080, and P=0.0034, respectively), and this effect was independent of sex ( Figure 1) . Notably, regardless of genotype, baseline HRs were significantly higher in females compared with males (P values by 2-factor ANOVA for effect of sex were P<0.0001, P=0.0345, and P<0.0001 for A 1 KOs [ Figure S15 ], A 2A KOs [ Figure 1 ], and A 2B KOs [ Figure  S16 ], respectively).
Next, we examined in both female and male A 1 KO, A 2A KO, and A 2B KO Dahl SS rats the effects of 14 days of either a 4% (high) or 8% (very high) salt diet. We limited the telemetry studies to 14 days of high-salt diet because after 14 days animals began to expire from sudden strokes. Over time, sudden strokes systematically removed the most severely hypertensive animals from the groups and therefore rendered statistical comparisons at time points past 14 days invalid.
The increases in MABPs (Figure 2 ), SBPs (Figure 2 ), and DBPs ( Figure S17 ) induced by a 4% salt diet were significantly attenuated by ≈26, 32, and 25 mm Hg, respectively, by the second week of a 4% salt diet in female A 1 KOs compared with female wild-type during the second week of the 4% salt diet (P value for the interaction between salt diet and genotype by 2-factor ANOVA was P<0.000001 for all 3 variables). In contrast to female A 1 KOs, male A 1 KOs were not protected against 4% salt diet-induced hypertension (Figure 2 ; Figure  S17 ). The sex dependence on the effects of A 1 KO genotype on 4% salt diet-induced hypertension was confirmed by 3-factor ANOVA (P values for the sex×salt diet×genotype interaction were P=0.0028, P=0.0016, and P=0.0034 for MABPs, SBPs, and DBPs, respectively). Notably, in wild-type females, HR increased during the second week of a 4% salt diet, and this increase was abolished in female A 1 KO rats ( Figure S17) . In a separate group of rats, we examined the effects of knocking out the A 1 receptor on hypertension induced by an 8% salt diet. Although in female rats knocking out the A 1 receptor attenuated 4% salt diet-induced hypertension, when the salt diet was 8% this protection was overwhelmed (Figures S18 and S19; P values for the salt diet×genotype interaction by 2-factor ANOVA were P=0.6848, P=0.8403, and P=0.8450 for MABPs, SBPs, and DBPs, respectively). In males, blood pressures tended to be higher in A 1 KOs on an 8% salt diet ( Figures S18 and S19) ; however, this trend did not achieve statistical significance (P values for the salt diet×genotype interaction by 2-factor ANOVA were P=0.2886, P=0.3144, and P=0.1552 for MABPs, SBPs, and DBPs, respectively).
Knocking out A 2A receptors did not increase the hypertensive response to the 4% salt diet in females ( Figures S20 and  S21 ). However, in male A 2A KOs (Figures S20 and S21) there was a strong tendency for an increased hypertensive response to 4% salt diet (P values for the salt diet×genotype interaction by 2-factor were P=0.0560, P=0.1070, and P=0.0706 for MABPs, SBPs, and DBPs, respectively). Although these 2-factor ANOVA P values did not achieve P<0.05, by 3-factor ANOVA, the sex×salt diet×genotype interaction was near significant for MABPs (P=0.0534; Figure S20 ) and reached significance for DBPs (P=0.0418; Figure S21 ). Taken together, these findings strongly suggest that male A 2A KOs, but not female A 2A KOs, were more sensitive to the prohypertensive effects of a 4% salt diet. The 8% salt diet revealed more clearly the detrimental effects of knocking out A 2A receptors. As shown in Figures 3 and 4 , there was a striking salt diet×genotype interaction (P values by 3-factor ANOVA were P=0.0010, P=0.0013, and P=0.0016 for MABPs, SBPs, and DBPs, respectively) that was independent of sex (P values for the sex×salt diet×genotype interaction were P=0.6703, P=0.8563, and P=0.9593 for MABPs, SBPs, and DBPs, respectively). In this regard, during the second week of an 8% salt diet, MABPs, SBPs, and DBPs were ≈13, 18, and 14 mm Hg, respectively, higher in A 2A KO females and ≈24, 22, and 18 mm Hg, respectively, higher in A 2A KO males compared with the corresponding wild-type females and males during the second week of an 8% salt diet.
Knocking out A 2B receptors yielded results similar to those observed in A 1 KO rats. During the second week of a 4% salt diet, MABPs, SBPs, and DBPs were significantly lower (by ≈36, 42, and 33 mm Hg) in female A 2B KOs compared with female wild-type rats ( Figure 5 ; Figure S22 ). In this regard, the P values for the salt diet×genotype interaction by 2-factor ANOVA in females were P=0.0002, P<0.0001, and P=0.0003 for MABPs, SBPs, and DBPs, respectively. In contrast to female A 2B KOs, male A 2B KOs were not protected against 4% salt diet-induced hypertension (P values by 2-factor ANOVA for the salt diet×genotype interaction in males were P=0.9927, P=0.9796, and P=0.9082 for MABPs, SBPs, and DBPs, respectively). The sex dependence on the effects of A 2B KO genotype on 4% salt diet-induced hypertension was confirmed by 3-factor ANOVA (the P values for the sex×salt diet×genotype interaction were P=0.0167, P=0.0092, and P=0.0333 for MABPs, SBPs, and DBPs, respectively). In yet another group of rats, we examined the effects of knocking out the A 2B receptor on hypertension induced by an 8% salt diet ( Figures S23 and S24) . Although in female rats knocking out the A 2B receptor was able to attenuate 4% salt diet-induced hypertension, when the salt diet was 8% this protection was overwhelmed (P values for the salt diet×genotype interaction by 2-factor ANOVA were P=0.7221, P=0.9383, and P=0.9532 for MABPs, SBPs, and DBPs, respectively). In males, MABPs, SBPs, and DBPs were similar in A 2B KOs versus wild-type on an 8% salt diet ( Figures S23 and S24) .
As mentioned, after 14 days of high-salt diet (either 4% or 8%), we observed that Dahl SS rats began to expire suddenly (ie, animals were very active, feeding, and grooming normally and in apparent good health; yet died suddenly). On occasion, an animal would develop partial paralysis in a limb or seizures, indicating that the likely cause of death was a sudden stroke. In several rats, we confirmed stroke in conscious rats by magnetic resonance imaging. Therefore, we monitored all animals at least 3× daily and immediately euthanized any rat that showed signs of limb paralysis or seizures. We noted the time of death or euthanasia and analyzed these data using the Gehan-Breslow-Wilcox test to compare survival curves because this test does not require a consistent hazard ratio. We analyzed survival curves after a 4% salt diet for each combination of sex and genotype and did the same for the 8% salt diet. However, to increase sample size (and thus robustness), we also analyzed survival curves for each combination of sex and genotype but combined the survival data for both high-salt diets (4%+8%). Knocking out A 2A receptors had no consistent effect on survival. Female, but not male, A 1 KOs had increased survival on a 4% salt diet (P=0.0382), but not on an 8% salt diet ( Figure S25 ). As shown in Figure 6 , female A 2B KOs had increased survival on 4% (P=0.0098), 8% (P=0.0404), and 4%+8% (P=0.0023) salt diets, whereas males did not.
Diurnal variation of blood pressure is a well-recognized phenomenon in which blood pressure is higher during the active phase (dark for rats) versus the inactive phase (light for rats) of the 24-hour dark-light cycle. Because it is conceivable that salt diet, genotype, or sex affected diurnal variation of blood pressure, we calculated the 7-day average MABP for each rat during the dark phase (lights off 7:00 pm to 7:00 am) and during the light phase (lights on 7:00 am to 7:00 pm) for each week of the telemetry study (prehigh-salt diet week, first week of high-salt diet, and second week of high-salt diet). We then calculated the diurnal variation of blood pressure as the dark phase minus light phase difference in MABP. As shown in Figures S26, S27 , and S28, the expected diurnal variation of MABP was observed in all groups, regardless of sex or genotype. Also, in all groups, a high-salt diet augmented the diurnal variation of MABP, particularly during the first week of a high-salt diet, and generally (but not always) less so during the second week of a high-salt diet.
Discussion
Here, we sought to provide a comprehensive blood pressure study to clarify the overall role of adenosine receptors in saltinduced hypertension. We selected salt diet as the prohypertensive stimulus because adenosine receptors are well-known to modulate renal excretory function. For example, using microdialysis, Siragy and Linden 56 observed in rats that renal interstitial levels of adenosine increased ≈18-fold in the cortex and medulla when the sodium diet was raised from 0.15% to 4%. Similarly, Zou et al 44 reported that a 4% NaCl diet significantly elevated cortical and medullary adenosine levels in snap-frozen kidneys. We established in 1993 that selective A 1 receptor antagonism markedly increases sodium excretion in rats, 14 and Zou et al 43 discovered in 1999 that A 2 receptors in the renal medulla dilate medullary vessels and thereby cause natriuresis.
Because of the potential importance of adenosine in regulating sodium excretion, we selected as our experimental paradigm the Dahl SS rat. Until recently, generating knockout rats was problematic; however, with the introduction of ZFN and CRISPR technology, that barrier has been removed. Therefore, we used this opportunity to establish colonies of Dahl SS rats with 3 of the major adenosine receptor subtypes deleted. We did not include A 3 receptor knockouts because there is little evidence for a role of this subtype in cardiovascular physiology. By using Dahl SS as the background strain and by placing these rats on an AIN-76A diet we now had the ability to induce large and reproducible increases in blood pressure by changing the salt diet.
To ensure that the target receptors were deleted in these novel rat strains, using Western blotting we examined adenosine receptor protein expression in the kidney medulla, juxtamedullary region, and cortex. Because the main purpose of these Western blot experiments was to ensure that the target receptors were knocked out, any tissue that expresses these receptors would have been informative. However, we selected to examine kidney tissue because (1) A 1 receptors modulate preglomerular vascular tone, vascular responses to renal sympathetic neurotransmission, and tubular sodium reabsorption; (2) A 2A receptors are involved in regulating blood flow to the medulla during salt loading; and (3) A 2B receptors are known to cause renal fibrosis in response to angiotensin II-induced hypertension (Introduction for references). The Western blot results indicated that the target receptors were deleted by the knockout strategy, and this conclusion was further reinforced by 4 additional experiments. First, the reverse transcription quantitative PCR results showed that the RNA for the target receptor was deleted in the respective knockout animals. Second, adenosine and CCPA (a highly selective A 1 receptor agonist) decreased HR and increased RVR in rats expressing A 1 receptors, but not in A 1 KO rats. Third, CGS21680 (a highly selective A 2A receptor agonist) decreased blood pressure in rats expressing A 2A receptors, but not in A 2A KO rats. Fourth, Bay60-6583 (a highly selective A 2B receptor agonist) decreased proliferation of CFs obtained from rats expressing A 2B receptors but did not affect proliferation of CFs obtained from A 2B KO rats. Taken together, these quality control experiments leave no doubt that the target receptors were deleted.
There are 3 important design aspects of the current study. First, we measured blood pressure in all rats using the goldstandard method of radiotelemetry. Second, we examined the effects of 3 different levels of salt diet on blood pressure. Third, we performed sufficient numbers of experiments in both females and males to permit inclusion of this critically important biological variable in a statistical approach designed to determine the effects of sex on outcomes. Inclusion of sex as a biological variable turned out to be essential for correct data interpretation.
There are 3 important conclusions that can be deduced from the present study. First, deletion of A 1 or A 2B receptors protects against salt-induced hypertension in females, but not males. However, this protection can be overcome when the salt diet reaches extremely high levels. Second, deletion of A 1 and A 2B receptors protects against salt-induced strokes in females, but not males, and this protection persists in A 2B KOs even when the salt diet is extremely high. Third, deletion of A 2A receptors augments salt-induced hypertension, an effect which occurs in both females and males, yet is more pronounced in males.
There are 3 implications of the above conclusions. One is that dual adenosine receptor antagonists that block both A 1 and A 2B receptors, but not A 2A receptors, may be useful antihypertensive and antistroke medications in females. In fact, it is conceivable that even males may derive benefit from dual blockade of A 1 and A 2B receptors. Indeed, recently we reported that administration of BG9928 for 24 weeks to male, obese ZSF 1 rats significantly improved left ventricular diastolic function in association with a reduction in cardiac vasculitis and cardiac necrosis. 57 BG9928 also significantly reduced focal segmental glomerulosclerosis, tubular atrophy, tubular dilation, and deposition of proteinaceous material in the tubules. 57 Although BG9928 is a highly potent A 1 receptor antagonist (K i , 7.4 nmol/L), it has some affinity for A 2B receptors (K i , 90 nmol/L) 58 ; however, BG9928 binds poorly to A 2A receptors (K i , 6410 nmol/L). 58 We are currently developing a colony of dual A 1 KO/A 2B KO Dahl rats to rigorously test the prediction that dual blockade of A 1 and A 2B receptors would provide increased benefit in females and perhaps some benefit in males. A second implication of the above conclusions is that a deficiency in A 2A receptor number or receptor-effector coupling or a deficiency in the levels of adenosine in the biophase of A 2A receptors could contribute to the pathophysiology of hypertension. A third implication is that drugs that increase adenosine levels in key biophases may be beneficial. For example, as mentioned salt diet increases adenosine levels in the renal medulla, an effect that dilates the renal medullary microvessels and promotes natriuresis. Therefore, agents that promote adenosine levels in the renal medulla may prove to be efficacious antihypertensives in both females and males.
Our motivation for examining the role of adenosine receptors in Dahl SS rats over a wide range of dietary salt levels (0.3%, 4%, and 8% salt diets) is that in humans there is a dose-response curve for dietary sodium intake versus arterial blood pressure that extends over a wide range (0.1-10 grams per day) of dietary sodium intake ( Figure 5 of article by Pettinger 59 ). The current study indicates that the protection against salt diet-induced hypertension afforded to females by knocking out A 1 or A 2B receptors is lost at very high levels (8%) of dietary salt. The clinical implication of this finding is that any benefit of blocking A 1 and A 2B receptors can be overridden by extremely high dietary sodium levels.
The main limitation of the present study is that we did not attempt to dissect the mechanisms by which deleting adenosine receptors affects blood pressure. This omission was by design. In our experience, manipulating animals perturbs blood pressure and compromises the quality, robustness, and rigor of the blood pressure data. Because our focus was on blood pressure, we decided against conducting any additional procedures. Also, we noted that Dahl SS rats on a high-salt diet were very susceptible to stroke. For example, on occasion merely the entry of animal care personnel into the telemetry room was associated with onset of strokes in some Dahl SS rats. We therefore decided to avoid all stressors and maintain animals in a quiet, highly controlled environment.
The fact that the beneficial effects of knocking out A 1 and A 2B receptors were limited to females is quite interesting and deserves comment. Our reverse transcription quantitative PCR experiments in kidneys and brains indicated that as a general rule mRNAs coding for adenosine receptor subtypes were similarly expression in females and males, and mRNA expression for a given adenosine receptor subtype was as a general rule not influenced by knockout of the other 2 adenosine receptor subtypes. However, we noted 2 exceptions to these general rules. First, A 2B receptor mRNA was ≈3-fold higher in the kidneys of female, compared with male, A 2A KOs ( Figure S7C ). Second, there was a strong trend for increased expression of A 2A receptor mRNA in the brains of female, compared with male, A 2B KOs ( Figure  S8B ). It is conceivable that deleting A 2A KOs in females was less prohypertensive because of compensation by increased expression of A 2B receptors in the renal microcirculation. Also increased A 2A receptors in the brain in A 2B KOs could have contributed to the antihypertensive effects of deleting A 2B receptors in females. Future studies focusing on these hypotheses are warranted.
Perspectives
An important aspect of this research is that it establishes beyond a reasonable doubt that A 1 , A 2A , and A 2B receptors play an important role in salt-sensitive hypertension. The present study therefore implies pharmacological approaches that may be used to prevent and treat hypertension. Finally, we should point out that a priori we had no strong rationale for including both females and males in this study. As it turned, the decision to do so was critically important. Therefore, the present study validates the recent recommendation by the National Institutes of Health to include sex as a biological variable whenever possible.
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